FENNEC PHARMACEUTICALS INC.

FENCSEC EDGAR

Biological Products, (No Diagnostic Substances)(A1)CIK: 1211583

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenues	$21.3M	$1.5M	—	$170.0K	—
Cost of Goods and Services Sold	—	$86.0K	$86.0K	—	—
Gross Profit	—	$1.4M	$1.4M	—	—
Research and Development Expense	$56.0K	$3.5M	$5.0M	$5.1M	$5.6M
Operating Expenses	$34.0M	$24.0M	$17.2M	$18.1M	$13.0M
Operating Income (Loss)	-$12.8M	-$22.6M	-$17.2M	-$17.9M	-$13.0M
Interest Expense	—	—	—	—	—

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$26.9M	$26.9M	$22.4M	$31.4M	$14.1M
Assets, Current	$26.9M	$26.7M	$22.4M	$31.4M	$13.9M
Cash and Cash Equivalents, at Carrying Value	$13.3M	$23.8M	$21.1M	$30.3M	$22.8M
Liabilities	$38.5M	$29.5M	$6.6M	$2.3M	$2.3M
Liabilities, Current	$7.6M	$4.6M	$1.7M	$2.3M	$2.3M
Long-term Debt	$19.3M	$30.9M	$24.9M	—	—
Accounts Payable, Current	$3.8M	$2.4M	$777.0K	$1.6M	$1.6M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$17.1M	-$18.1M	-$14.2M	-$15.6M	-$9.1M
Net Cash Provided by (Used in) Investing Activities	—	—	—	—	—
Net Cash Provided by (Used in) Financing Activities	$6.6M	$20.7M	$5.0M	$32.3M	-$71.0K
Payments to Acquire Property, Plant, and Equipment	—	—	—	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)